294 related articles for article (PubMed ID: 21320040)
1. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.
Stieger B; Geier A
Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):411-25. PubMed ID: 21320040
[TBL] [Abstract][Full Text] [Related]
2. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.
Pauli-Magnus C; Meier PJ; Stieger B
Semin Liver Dis; 2010 May; 30(2):147-59. PubMed ID: 20422497
[TBL] [Abstract][Full Text] [Related]
3. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
Stieger B
Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
[TBL] [Abstract][Full Text] [Related]
4. Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools.
de Lima Toccafondo Vieira M; Tagliati CA
Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):581-97. PubMed ID: 24588537
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
[TBL] [Abstract][Full Text] [Related]
6. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
[TBL] [Abstract][Full Text] [Related]
7. Maternal cholestasis does not affect the ontogenic pattern of expression of the Na+/taurocholate cotransporting polypeptide (ntcp) in the fetal and neonatal rat liver.
Arrese M; Trauner M; Ananthanarayanan M; Boyer JL; Suchy FJ
Hepatology; 1998 Sep; 28(3):789-95. PubMed ID: 9731574
[TBL] [Abstract][Full Text] [Related]
8. Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump.
Mita S; Suzuki H; Akita H; Stieger B; Meier PJ; Hofmann AF; Sugiyama Y
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G159-67. PubMed ID: 15297262
[TBL] [Abstract][Full Text] [Related]
9. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis.
Gartung C; Matern S
Yale J Biol Med; 1997; 70(4):355-63. PubMed ID: 9626756
[TBL] [Abstract][Full Text] [Related]
10. Bile acid transporters: structure, function, regulation and pathophysiological implications.
Alrefai WA; Gill RK
Pharm Res; 2007 Oct; 24(10):1803-23. PubMed ID: 17404808
[TBL] [Abstract][Full Text] [Related]
11. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.
Rost D; Herrmann T; Sauer P; Schmidts HL; Stieger B; Meier PJ; Stremmel W; Stiehl A
Hepatology; 2003 Jul; 38(1):187-95. PubMed ID: 12830001
[TBL] [Abstract][Full Text] [Related]
12. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis.
Stieger B
Drug Metab Rev; 2010 Aug; 42(3):437-45. PubMed ID: 20028269
[TBL] [Abstract][Full Text] [Related]
13. The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease.
Lam P; Soroka CJ; Boyer JL
Semin Liver Dis; 2010 May; 30(2):125-33. PubMed ID: 20422495
[TBL] [Abstract][Full Text] [Related]
14. Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis.
Burbank MG; Burban A; Sharanek A; Weaver RJ; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2016 Nov; 44(11):1780-1793. PubMed ID: 27538918
[TBL] [Abstract][Full Text] [Related]
15. Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump.
Meier Y; Zodan T; Lang C; Zimmermann R; Kullak-Ublick GA; Meier PJ; Stieger B; Pauli-Magnus C
World J Gastroenterol; 2008 Jan; 14(1):38-45. PubMed ID: 18176959
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function.
Telbisz Á; Homolya L
Expert Opin Ther Targets; 2016; 20(4):501-14. PubMed ID: 26573700
[TBL] [Abstract][Full Text] [Related]
17. Effect of drug transporter pharmacogenetics on cholestasis.
Dietrich CG; Geier A
Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1533-51. PubMed ID: 25260651
[TBL] [Abstract][Full Text] [Related]
18. Review article: The function and regulation of proteins involved in bile salt biosynthesis and transport.
Pellicoro A; Faber KN
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():149-60. PubMed ID: 18081658
[TBL] [Abstract][Full Text] [Related]
19. Bile salt transporters: molecular characterization, function, and regulation.
Trauner M; Boyer JL
Physiol Rev; 2003 Apr; 83(2):633-71. PubMed ID: 12663868
[TBL] [Abstract][Full Text] [Related]
20. Molecular and Clinical Links between Drug-Induced Cholestasis and Familial Intrahepatic Cholestasis.
Vitale G; Mattiaccio A; Conti A; Berardi S; Vero V; Turco L; Seri M; Morelli MC
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]